Shanghai No.1 Pharmacy Co.,Ltd. (SHA:600833)
10.69
+0.02 (0.19%)
Sep 8, 2026, 11:00 AM CST
Shanghai No.1 Pharmacy Revenue
Shanghai No.1 Pharmacy had revenue of 497.01M CNY in the quarter ending June 30, 2026, with 0.89% growth. This brings the company's revenue in the last twelve months to 2.12B, up 4.79% year-over-year. In the year 2025, Shanghai No.1 Pharmacy had annual revenue of 2.13B with 11.23% growth.
Revenue (ttm)
2.12B
Revenue Growth
+4.79%
P/S Ratio
1.13
Revenue / Employee
2.59M
Employees
818
Market Cap
2.38B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.13B | 215.08M | 11.23% |
| Dec 31, 2024 | 1.92B | 95.64M | 5.26% |
| Dec 31, 2023 | 1.82B | -836.39M | -31.49% |
| Dec 31, 2022 | 2.66B | 1.26B | 89.94% |
| Dec 31, 2021 | 1.40B | -188.62M | -11.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DaShenLin Pharmaceutical Group | 27.97B |
| Yifeng Pharmacy Chain | 24.84B |
| LBX Pharmacy Chain Joint Stock Company | 22.46B |
| Luyan Pharma | 21.43B |
| Cachet Pharmaceutical | 18.10B |
| Yixintang Pharmaceutical Group | 16.89B |
| ShuYu Civilian Pharmacy Corp. | 10.76B |
| Jianzhijia Pharmaceutical Chain Group | 8.65B |